Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation

Details for Australian Patent Application No. 2006268374 (hide)

International Classifications

Event Publications

31 January 2008 PCT application entered the National Phase

PCT publication WO2007/008821 Priority application(s): WO2007/008821

20 March 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name SIRiON Theraputics, Inc., Application No. 2006268374, Under INID (71), correct the name to SIRiON Therapeutics, Inc.

22 May 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 24 Apr 2008

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.